Pembrolizumab plus Lenvatinib in patients with metastatic Renal Cell Carcinoma: real-world evidences from the international ARON- 1 study. - Porta C; Massari F; Taha T; Grande E; Bourlon MT; Kanesvaran R; Basso U; Molina-Cerrillo J; Alonso-Gordoa T; Myint ZW; Fornarini G; Buttner T; et al. (Cancer immunology, immunotherapy : CII, 2025)